glp-1 manufacturers in india Rapid Growth of the Drug Market: Trends, Players, and Future Prospects Which Pharma Players Will Lead

Among more than 6,800 colon cancer patients in a 2024 study, around 16% of the 103 on a GLP-1 drug died within five years compared to 37% of those who were not taking one

Understanding the reason youre switching can help ensure a smoother transition and better support your health goals

The approval of biosimilar insulins may improve accessibility at lower treatment costs

Since the trial failed, the company also announced that theyre halting the one-year open label extension trial period, where all participants including those who initially received the placebo, would have the opportunity to take the drug

They had performed the test on blood drawn from ten patients with insulinomas